Director Patel Gautam sold Amneal Pharmaceuticals ($AMRX) shares on the open market five times over the past year, totaling $1.95 million, with the latest sale on June 16, 2025. These sales rank 3,556th among 11,678 insiders in our database, below the average of $8.6 million per seller and 6.4 transactions. Gautam made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | Spectrum Brands Holdings, Inc. | $SPB | Patel Gautam | Director | A | Common Stock | 4602 | $0.00 | 22,141.0000 | 23,700,000 | 26.24% | 0.02% |
| June 16, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 94906 | $8.02 | 1,609,144.0000 | 308,978,000 | 5.57% | 0.03% |
| June 10, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 56426 | $8.02 | 1,704,050.0000 | 308,978,000 | 3.21% | 0.02% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | M | Class A Common Stock | 40258 | $0.00 | 1,760,476.0000 | 308,978,000 | 2.34% | 0.01% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | M | Restricted Stock Units | 40258 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| May 6, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | A | Restricted Stock Units | 34819 | $0.00 | 34,819.0000 | 308,978,000 | 9999.99% | 0.01% |
| May 2, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 3768 | $8.00 | 1,725,118.0000 | 308,978,000 | 0.22% | 0.00% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 4900 | $8.00 | 1,720,218.0000 | 308,978,000 | 0.28% | 0.00% |
| April 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 80000 | $8.30 | 1,728,886.0000 | 308,978,000 | 4.42% | 0.03% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 80000 | $8.90 | 1,808,886.0000 | 308,978,000 | 4.24% | 0.03% |
| Feb. 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 80000 | $8.14 | 1,888,886.0000 | 308,978,000 | 4.06% | 0.03% |
| Jan. 8, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 62590 | $8.01 | 1,968,886.0000 | 308,978,000 | 3.08% | 0.02% |
| Jan. 2, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | S | Class A Common Stock | 17410 | $8.01 | 2,031,476.0000 | 308,978,000 | 0.85% | 0.01% |
| Nov. 19, 2024 | Spectrum Brands Holdings, Inc. | $SPB | Patel Gautam | Director | A | Common Stock | 2770 | $90.26 | 17,539.0000 | 28,000,000 | 18.76% | 0.01% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | M | Class A Common Stock | 76453 | $0.00 | 2,048,886.0000 | 176,136,000 | 3.88% | 0.04% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | M | Restricted Stock Units | 76453 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.04% |
| May 2, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | A | Restricted Stock Units | 40258 | $0.00 | 40,258.0000 | 176,136,000 | 9999.99% | 0.02% |
| Jan. 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Not found | J | Class A Common Stock | 33458067 | $0.00 | 374,318.0000 | 176,136,000 | 98.89% | 19.00% |
| Jan. 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Not found | G | Class A Common Stock | 1598115 | $0.00 | 1,972,433.0000 | 176,136,000 | 426.94% | 0.91% |
| Dec. 1, 2021 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Not found | J | Class A Common Stock | 3073298 | $0.00 | 15,960,731.0000 | 0 | 23.85% | 0.00% |
| Nov. 7, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | J | Class B Common Stock and Common Units | 17497336 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 11.59% |
| Nov. 7, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | J | Class A Common Stock | 17497336 | $0.00 | 30,759,087.0000 | 150,944,000 | 131.94% | 11.59% |
| May 9, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | A | Restricted Stock Units | 76453 | $0.00 | 76,453.0000 | 150,944,000 | 9999.99% | 0.05% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | M | Restricted Stock Units | 80128 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.05% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Gautam | Director | M | Class A Common Stock | 80128 | $0.00 | 13,261,751.0000 | 150,944,000 | 0.61% | 0.05% |